PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
XBIO vs. VGR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

XBIO vs. VGR

Last updated Apr 26, 2025

Compare and contrast key facts about Xenetic Biosciences, Inc. (XBIO) and Vector Group Ltd. (VGR).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XBIO or VGR.

Correlation

The correlation between XBIO and VGR is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

-0.50.00.51.0
Correlation: 0.1

Performance

XBIO vs. VGR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Xenetic Biosciences, Inc. (XBIO) and Vector Group Ltd. (VGR). The values are adjusted to include any dividend payments, if applicable.
-100.00%-50.00%0.00%50.00%100.00%150.00%200.00%250.00%NovemberDecember2025FebruaryMarchApril
-99.91%
211.20%
XBIO
VGR

Key characteristics

Fundamentals

Market Cap

XBIO:

$4.16M

VGR:

$2.36B

EPS

XBIO:

-$2.72

VGR:

$1.26

PEG Ratio

XBIO:

0.00

VGR:

2.96

PS Ratio

XBIO:

1.66

VGR:

2.48

PB Ratio

XBIO:

0.65

VGR:

0.00

Total Revenue (TTM)

XBIO:

$1.99M

VGR:

$371.91M

Gross Profit (TTM)

XBIO:

$1.99M

VGR:

$127.32M

EBITDA (TTM)

XBIO:

-$2.94M

VGR:

$101.41M

Returns By Period

XBIO

YTD

-30.02%

1M

-14.61%

6M

-26.42%

1Y

-26.05%

5Y*

-21.63%

10Y*

-44.52%

VGR

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

XBIO vs. VGR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
XBIO
The Risk-Adjusted Performance Rank of XBIO is 2828
Overall Rank
The Sharpe Ratio Rank of XBIO is 3131
Sharpe Ratio Rank
The Sortino Ratio Rank of XBIO is 3333
Sortino Ratio Rank
The Omega Ratio Rank of XBIO is 3434
Omega Ratio Rank
The Calmar Ratio Rank of XBIO is 3535
Calmar Ratio Rank
The Martin Ratio Rank of XBIO is 88
Martin Ratio Rank
VGR
The Risk-Adjusted Performance Rank of VGR is 8484
Overall Rank
The Sharpe Ratio Rank of VGR is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of VGR is 8383
Sortino Ratio Rank
The Omega Ratio Rank of VGR is 8484
Omega Ratio Rank
The Calmar Ratio Rank of VGR is 8787
Calmar Ratio Rank
The Martin Ratio Rank of VGR is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

XBIO vs. VGR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Xenetic Biosciences, Inc. (XBIO) and Vector Group Ltd. (VGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The chart of Sharpe ratio for XBIO, currently valued at -0.39, compared to the broader market-2.00-1.000.001.002.003.00
XBIO: -0.39
VGR: 2.31
The chart of Sortino ratio for XBIO, currently valued at -0.14, compared to the broader market-6.00-4.00-2.000.002.004.00
XBIO: -0.14
VGR: 3.23
The chart of Omega ratio for XBIO, currently valued at 0.98, compared to the broader market0.501.001.502.00
XBIO: 0.98
VGR: 1.93
The chart of Calmar ratio for XBIO, currently valued at -0.27, compared to the broader market0.001.002.003.004.005.00
XBIO: -0.27
VGR: 1.66
The chart of Martin ratio for XBIO, currently valued at -1.51, compared to the broader market-5.000.005.0010.0015.0020.00
XBIO: -1.51
VGR: 34.86

Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.39
2.31
XBIO
VGR

Dividends

XBIO vs. VGR - Dividend Comparison

Neither XBIO nor VGR has paid dividends to shareholders.

TTM20242023202220212020201920182017201620152014
XBIO
Xenetic Biosciences, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VGR
Vector Group Ltd.		2.67%4.00%7.09%6.75%4.94%6.87%11.66%16.05%6.98%6.87%6.62%7.33%

Drawdowns

XBIO vs. VGR - Drawdown Comparison

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-99.93%
-0.13%
XBIO
VGR

Volatility

XBIO vs. VGR - Volatility Comparison

Xenetic Biosciences, Inc. (XBIO) has a higher volatility of 26.28% compared to Vector Group Ltd. (VGR) at 0.00%. This indicates that XBIO's price experiences larger fluctuations and is considered to be riskier than VGR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

0.00%5.00%10.00%15.00%20.00%25.00%30.00%NovemberDecember2025FebruaryMarchApril
26.28%
0
XBIO
VGR

Financials

XBIO vs. VGR - Financials Comparison

This section allows you to compare key financial metrics between Xenetic Biosciences, Inc. and Vector Group Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

Values in USD except per share items